MONITORING INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER USING FLUORESCENCE IN SITU HYBRIDIZATION-Reference-Cited by-同舟云学术

MONITORING INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER USING FLUORESCENCE IN SITU HYBRIDIZATION

Published:2005-02 Issue:2 Volume:173 Page:401-404
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

KIPP BENJAMIN R.¹,KARNES R. JEFFREY¹,BRANKLEY SHANNON M.¹,HARWOOD AARON R.¹,PANKRATZ V. SHANE¹,SEBO THOMAS J.¹,BLUTE MICHAEL M.¹,LIEBER MICHAEL M.¹,ZINCKE HORST¹,HALLING KEVIN C.¹

Affiliation:

1. From the Departments of Laboratory Medicine and Pathology (BRK, SMB, ARH, TJS, KCH), Urology (RJK, MMB, MML, HZ) and Biostatistics (VSP) Mayo Clinic and Foundation, Rochester, Minnesota

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Cancer Statistics, 2003

2. Evaluation and follow-up strategies for superficial bladder cancer

3. THE NATURAL HISTORY OF BLADDER CANCER

4. CURRENT USE AND QUESTIONS CONCERNING INTRAVESICAL BLADDER CANCER GROUP FOR SUPERFICIAL BLADDER CANCER

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment;Journal of Urology;2024-04

2. Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers;International Journal of Molecular Sciences;2023-09-21

3. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape;Société Internationale d’Urologie Journal;2022-07-15

4. Ancillary Studies in Urinary Cytology;The Paris System for Reporting Urinary Cytology;2022

5. The Use of Urine Mycobacterium tuberculosis Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guérin Therapy in Patients with Non–muscle‑invasive Bladder Cancer;European Urology Open Science;2021-05